112 related articles for article (PubMed ID: 37861711)
1. Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers.
Turanli B
OMICS; 2023 Oct; 27(10):483-493. PubMed ID: 37861711
[TBL] [Abstract][Full Text] [Related]
2. Forecasting Gastric Cancer Diagnosis, Prognosis, and Drug Repurposing with Novel Gene Expression Signatures.
Demirtas TY; Rahman MR; Yurtsever MC; Gov E
OMICS; 2022 Jan; 26(1):64-74. PubMed ID: 34910889
[TBL] [Abstract][Full Text] [Related]
3. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract][Full Text] [Related]
5. Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA).
Danaher P; Warren S; Lu R; Samayoa J; Sullivan A; Pekker I; Wallden B; Marincola FM; Cesano A
J Immunother Cancer; 2018 Jun; 6(1):63. PubMed ID: 29929551
[TBL] [Abstract][Full Text] [Related]
6. A Transcriptomic and Reverse-Engineering Strategy Reveals Molecular Signatures of Arachidonic Acid Metabolism in 12 Cancers.
Oktem EK; Aydin B; Gulfidan G; Arga KY
OMICS; 2023 Mar; 27(3):127-138. PubMed ID: 36800175
[TBL] [Abstract][Full Text] [Related]
7. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
8. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses.
Islam T; Rahman R; Gov E; Turanli B; Gulfidan G; Haque A; Arga KY; Haque Mollah N
OMICS; 2018 Jun; 22(6):422-436. PubMed ID: 29927717
[TBL] [Abstract][Full Text] [Related]
9. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance.
Li Z; Chen J; Zhu D; Wang X; Chen J; Zhang Y; Lian Q; Gu B
BMC Genom Data; 2022 Jul; 23(1):51. PubMed ID: 35794546
[TBL] [Abstract][Full Text] [Related]
11. A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets.
Fu X; Ji F; He Q; Qiu X
J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393
[TBL] [Abstract][Full Text] [Related]
12. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of TMEM59L and its genomic and immunological characteristics in cancer.
Shi C; Zhang L; Chen D; Wei H; Qi W; Zhang P; Guo H; Sun L
Front Immunol; 2022; 13():1054157. PubMed ID: 36618425
[TBL] [Abstract][Full Text] [Related]
15. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
16. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer.
Liu W; Zhu M; Li X; Er L; Li S
Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086
[TBL] [Abstract][Full Text] [Related]
17. The pan-cancer analysis of gene expression patterns in the context of inflammation.
Yu X; Lian B; Wang L; Zhang Y; Dai E; Meng F; Liu D; Wang S; Liu X; Wang J; Li X; Jiang W
Mol Biosyst; 2014 Jul; 10(9):2270-6. PubMed ID: 24958091
[TBL] [Abstract][Full Text] [Related]
18. Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.
Uddin MN; Li M; Wang X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500382
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
